Episode 37: Ask Me Anything with AACE 2023 Plenary Experts
In this podcast endocrine expert David C. Lieb, MD, FACP, FACE, interviews our AACE 2023 award-winning plenary speakers, Elizabeth N. Pearce, MD, MSc, FACE, Irl Hirsch, MD, and Richard J. Auchus, MD, ...
3 Huhti 202347min
Episode 36: The Science Behind Vaccines - What the Endocrine Care Team Should Know
There is varying knowledge among members of the endocrine care team about the vaccines AACE recommends for persons with diabetes that are included in the updated 2022 AACE Diabetes Guideline. In this ...
10 Maalis 202325min
Episode 35: 2022 AACE Diabetes Guideline Update
Join endocrine experts S. Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, Susan L. Samson, MD, PhD, FRCPC, FACE, and Vin Tangpricha, MD, FACE, as they discuss the 2022 AACE diabetes clinical practice guid...
13 Joulu 202227min
Episode 34: International Medical Graduate’s Experience and Recommendations
Listen to endocrine experts, Vinni Makin, MD, Joumana Chaiban, MD, and Ricardo Correa, MD, share their personal experiences about how they obtained a visa as international medical graduates and transi...
29 Syys 202248min
Episode 33: Strategies for Increasing Vaccination Rates for Persons with Diabetes
For persons with diabetes, vaccinations have been shown to help them from contracting and experiencing more severe outcomes from preventable illnesses, such as influenza and Covid-19. It is important ...
27 Syys 202227min
Episode 32: Adrenal Insufficiency
Adrenal insufficiency is a life-threatening condition but diagnosis is typically delayed. The initial presentation is often non-specific and physician awareness must be improved to avoid adrenal crisi...
13 Heinä 202240min
Episode 31: 2022 AACE Nonalcoholic Fatty Liver Disease Clinical Practice Guideline. Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)
Nonalcoholic fatty liver disease (NAFLD) is a major public health problem that will only worsen in the future, as it is closely linked to the epidemics of obesity and type 2 diabetes mellitus. Given t...
11 Heinä 202228min
Episode 29: Triglycerides in Cardiovascular Disease Prevention Part 1
The landmark Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT®) was a global outcomes study designed to assess the cardioprotective efficacy and safety of VASCEPA®...
8 Heinä 202215min
